EarningsBXPHARMA
BXPHARMA Earnings Update
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 24 June 2026. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q3 Un-audited): Consolidated EPS was Tk. 3.86 for January-March 2025 as against Tk. 3.06 for January-March 2024; Consolidated EPS was Tk. 11.73 for July 2024-March 2025 as against Tk. 9.75 for July 2023-March 2024. Consolidated NOCFPS was Tk. 9.46 for July 2024-March 2025 as against Tk. 14.79 for July 2023-March 2024. Consolidated NAV per share was Tk. 115.21 as on March 31, 2025 and Tk. 104.17 as on March 31, 2024.
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 6a3b51cc00e9a19e44f8efca
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.